Status:
COMPLETED
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Healthy, no Evidence of Disease
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Studying samples of blood, urine, sputum, mouth cells, and bronchial tissue from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and ident...
Detailed Description
OBJECTIVES: * To obtain biological specimens from healthy participants with no known risk of lung cancer to use as controls in the study of lung cancer progression. * To identify new molecular abnorm...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Healthy participant
- No history of smoking
- No history of cancer
- PATIENT CHARACTERISTICS:
- SWOG performance status 0
- No clinically apparent bleeding diathesis
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00899457
Start Date
April 1 2008
End Date
August 1 2010
Last Update
June 24 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States, 37064
2
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States, 37064
3
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838